Title: Innovations by Eugenio A Cefali
Introduction
Eugenio A Cefali is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceuticals, particularly in formulations that address common side effects associated with medication. His work focuses on improving patient comfort and treatment efficacy.
Latest Patents
Eugenio A Cefali holds two notable patents. The first is for a "Low Flush Niacin Formulation," which relates to an extended-release matrix formulation capable of being directly compressed into tablets. This formulation includes niacin, a release-retarding agent, and other excipients. The resulting tablets demonstrate favorable release characteristics and a reduction in the severity, duration, and incidences of cutaneous flushing commonly associated with niacin treatment. The second patent is titled "Methods Of Pretreating Hyperlipidemic Individuals With A Flush Inhibiting Agent Prior To The Start Of Single Daily Dose Nicotinic Acid Therapy To Reduce Flushing Provoked By Nicotinic Acid." This invention involves pretreating individuals with an effective amount of a flush inhibiting agent prior to starting nicotinic acid therapy. The method aims to reduce the flushing reactions that can occur during treatment.
Career Highlights
Eugenio A Cefali is associated with Kos Life Sciences, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing formulations that enhance the therapeutic experience for patients.
Collaborations
Eugenio has collaborated with notable colleagues, including Jose G Rocca and Yucun Zhu, contributing to advancements in their shared field of expertise.
Conclusion
Eugenio A Cefali's contributions to pharmaceutical innovations demonstrate his commitment to improving patient care through effective formulations. His work continues to influence the industry positively.